HEALTH TECHNOLOGY

Philips advances AI-powered diagnostic systems and transformative workflow solutions at RSNA 2022

Royal Philips | November 28, 2022 | Read time : 04:00 min

Philips advances

Royal Philips a global leader in health technology announced its portfolio of smart diagnostic systems and transformative workflow solutions featured at the Radiological Society of North America annual meeting. Powered by AI, the company will showcase its latest systems and informatics solutions designed for providers to efficiently deliver patient-centric, high-quality imaging services.

Overwhelming volume of radiology data compounding staff shortages and burnout
Radiology plays a critical role in diagnosing and guiding patients into the right treatment plans. However, with increasing staff shortages and workloads, radiologists and staff continue to struggle to manage and interpret the huge volume of data captured to provide quality care for each patient. In the recent Future Health Index 2022 report commissioned by Philips, 24% of radiology leaders surveyed stated that managing the sheer volume of data available to them is their top data-related issue, with nearly two-thirds (65%) indicating their staff are overwhelmed by data overload.

With 47% of radiologists experiencing burnout [1], our customers are looking for innovations to help reduce their workloads and seamlessly integrate into their day-to-day operations. With smart intelligence built into imaging systems and informatics across the radiology workflow, Philips’ integrated solutions condense large volumes of data into patient-centric actionable insights for earlier and more definitive diagnosis and treatment.”

Kees Wesdorp, Chief Business Leader of Precision Diagnosis at Philips

AI-powered solutions enhance operational efficiencies and simplify complex workflows
Some of the biggest challenges facing radiology leaders today are driven by managing complex, disconnected workflows which can negatively impact patient care, staff experience, outcomes, and cost. Visitors to the Philips booth at RSNA will see how the company’s latest interoperable and vendor-neutral operational solutions and strong portfolio of smart connected imaging systems help streamline and transform the radiology workflow to improve patient and staff experience; advance clinical and diagnostic confidence for better health outcomes; and drive a sustainable, resilient diagnostic infrastructure to help lower the cost of care. Featured at RSNA will be Philips’ AI-enabled technology [2] that automates and accelerates routine and repetitive tasks to generate patient-centric insights from large volumes of data to help improve productivity.

Solutions include Philips Imaging Orchestrator – ROCC and Philips Ultrasound Collaboration Live, both pioneering the virtualization of radiology, extending care and collaboration beyond traditional models. Philips Imaging Orchestrator – ROCC, a vendor-neutral, multi-modality, multi-site telepresence solution provides advanced tele-acquisition capabilities and seamlessly connects imaging experts at a command center with technologists at scanning locations across an organization. Philips Ultrasound Collaboration Live tele-ultrasound, available on Philips ultrasound systems – EPIQ Elite and Affiniti – allows teams to securely video stream from their ultrasound system to a PC or mobile device for remote, on-demand access to clinical expertise regardless of location.

Philips will also introduce the latest in AI-enabled image interpretation to help prioritize patient worklists based on clinical outcomes and expand diagnostic capabilities with its new Philips Advanced Visualization Workspace, with enhanced features to automate reporting and help drive earlier and more definitive diagnosis. Also featured is Philips Enterprise Performance Analytics – PerformanceBridge – to enhance operational decision-making through a vendor-neutral, real-time data analysis solution to help improve productivity and reduce costs. 

Smart connected imaging systems advance clinical and diagnostic confidence
New at RSNA, Philips’ AI-powered MR SmartSpeed is designed to increase speed, image quality, and productivity and drive diagnostic confidence with improved image resolution via the AI reconstruction algorithm. It utilizes Philips’ state-of-the-art speed engine and an award-winning [3] AI reconstruction technology delivered at the source of the MR signal to ensure no data loss. SmartSpeed joins the company’s expanding portfolio of AI-driven MR solutions which includes AI-based touchless patient sensing, SmartExam, and MR Workspace. Philips will also showcase MR 5300, Philips’ newest BlueSeal Magnet, and industry-first wide bore helium-free operations system design for sustainable imaging at lower site costs without image quality or clinical compromises.

Philips will spotlight its award-winning Spectral CT 7500, the company’s latest dual-detector CT system helping radiologists better characterize disease and reduce scan times at the same dose levels as conventional scans. Used in oncology imaging, cardiac imaging, and interventional radiology, the system has demonstrated a 34% reduction in time to diagnosis, a 25% reduction in repeat scans and a 30% reduction in follow-up scans [4]. Philips will also demonstrate its latest innovations in minimally-invasive care with the company’s SmartCT 3D suite of interventional tools including its Azurion 7 C20 with FlexArm Image-Guided Therapy System and Zenition 70 Mobile C-arm with Flat Detector.

Philips will also introduce the Ultrasound Compact 5000 Series system and the Philips Lumify Handheld Ultrasound, now featuring pulse wave Doppler for all physicians – from cardiologists and radiologists to emergency care – to quickly assess hemodynamics in cardiac function anytime, anywhere. Also making its first appearance at RSNA is Philips Fluoroscopy 7000 N – ProxiDiagnost N90, combining digital radiography and high-end nearby fluoroscopy to help enhance clinical confidence and improve patient and staff satisfaction.  

About Royal Philips
Royal Philips is a leading health technology company focused on improving people's health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2021 sales of EUR 17.2 billion and employs approximately 79,000 employees with sales and services in more than 100 countries. 

Spotlight

Initiated in 2009, Hunan Beyond Medical Technology Co., Ltd. (Beyond for short) , based in Yuelu District, Changsha with the registration capital of 30.48 million RMB, is dedicated to R&D, manufacturing, marketing and service of product solutions in medical healthcare industry.

Spotlight

Initiated in 2009, Hunan Beyond Medical Technology Co., Ltd. (Beyond for short) , based in Yuelu District, Changsha with the registration capital of 30.48 million RMB, is dedicated to R&D, manufacturing, marketing and service of product solutions in medical healthcare industry.

Related News

DIGITAL HEALTHCARE, HEALTHCARE ANALYTICS

Long-Duration Ultrasound Treatment With sam® Elevates Regenerative Medicine Options for Patients

ZetrOZ Systems | December 13, 2022

Sustained Acoustic Medicine technology, the FDA-cleared ultrasound device created by ZetrOZ Systems, continues to demonstrate its ability to relieve pain and accelerate patients' return to sports, work and other daily activities. Now, medical professionals can administer the innovative technology as a pre- and post-treatment recovery option for regenerative medicine injectable treatments such as platelet-rich plasma and other autologous cellular-based therapies. PRP injections are safe, autologous blood products containing growth factors and cytokines with the potential to alter biological processes and support the three phases of tissue healing: inflammation, proliferation, and remodeling. PRP injections are commonly administered in the doctor's office multiple times over six to 12 months and may be painful to some patients. sam® offers a non-invasive, daily, home-use treatment option for pain and tissue remodeling, which is a powerful technology to complement PRP injections and other regenerative medicine therapies. "Sustained acoustic medicine is a powerful mechanobiological treatment modality," said Dr. George Lewis, founder and CEO of ZetrOZ Systems. "Each treatment increases vessel diameter to boost blood flow over several hours, accelerating tissue healing and delivering a significant reduction in pain for patients. The use of ultrasound and shockwave treatment in the clinical setting to complement rehabilitation and regenerative medicine is broadly used. sam® is the first long-duration ultrasound treatment available for prescription home use." The use of sam® is also continuing to expand in the professional sports medicine market, with ongoing use by 75% of professional and college affiliations, including the NFL, NBA, MLS, WBNA, MLB and the ACC. ZetrOZ Systems also partners with all professional sports organizations and sports medicine providers in Atlanta, GA, and are proud supporters of the healthcare and athletic training societies of the NFL, MLB, NHL, NBA and MLS. sam® treats over 35% of muscle and tendon injuries without surgery, helping elite athletes and professionals in physically demanding jobs get pain relief and natural healing. "Surgery is not always the best course of action for our athletes, and sam® technology offers a pathway to recovery without invasive surgery that can have risks and implications immediately or in the future," Lewis said. Ultrasound therapy continues to show promise, with more than 40 peer-reviewed studies showing that sam® offers faster healing after injury or surgery. These findings can empower care providers to offer this easy-to-use regenerative device that leads to better outcomes, happier patients, and lowers healthcare system costs. The technology can serve as a standalone treatment or adjunct to other treatment options for patients to stimulate soft-tissue repair. About ZetrOZ Systems ZetrOZ Systems is leading healing innovation in sports medicine, developing wearable bioelectronic devices for the delivery of sustained acoustic medicine (sam®). Researched and funded by the federal government, ZetrOZ is built on proprietary medical technology of +46 patents. The exclusive manufacturer and developer of the sam® product line is designed for the treatment of acute and chronic musculoskeletal conditions.

Read More

HEALTHTECH SECURITY, DIGITAL HEALTHCARE

CHA Hollywood Presbyterian Medical Center Launches Fetal Surgery Program

CHA Hollywood Presbyterian Medical Center | January 23, 2023

Hollywood Presbyterian Medical Center (CHA HPMC), a member of CHA Health Systems, recently announced a new partnership with Los Angeles Fetal Surgery to provide life-saving and revolutionary fetal surgery to pregnant women and their unborn babies with birth defects. It will be the only fetal surgery center in the U.S. Los Angeles Fetal Surgery, a joint program between USC and Children's Hospital Los Angeles, offers minimally invasive fetal treatments to reduce or cure adverse outcomes due to fatal conditions, which would otherwise result in the baby's death or irreversible organ damage. Dr. Ramen Chmait, an international expert in minimally invasive fetal surgery, will direct the program. He has produced over 200 manuscripts and book chapters in fetal medicine and surgery over the past 20 years. "The goal of the Los Angeles Fetal Surgery Program at CHA Hollywood Presbyterian is to treat unborn babies with innovative treatments while providing families with emotional support," said Ramen Chmait, MD, who also serves as an OB-GYN with Keck Medicine of USC. (Source- Business Wire) "Our collaborative structure ensures our patients have access to a wide variety of services and specialists. This affiliation with CHA HPMC only strengthens our commitment to successful outcomes,” he further added. (Source- Business Wire) According to the CDC, 1 in 33 U.S. newborns is born with a serious condition. The program will treat Spina Bifida, Vasa Previa, and Twin-Twin Transfusion Syndrome. CHA HPMC, Los Angeles' second-largest maternity center, provides excellent prenatal and postpartum care. Fetal surgery will help CHA HPMC serve its community and improve results for expectant families. About CHA Hollywood Presbyterian Medical Center CHA Hollywood Presbyterian Medical Center (CHA HPMC) is a full-service hospital, providing acute care to the multicultural population of Hollywood and its neighboring regions since 1924. CHA Bio Group is known worldwide for its high-quality health care and advances in reproductive medicine. CHA HPMC has 469 acute care beds and 89 skilled nursing beds. The hospital employs about 550 doctors from 69 disciplines and 75 nationalities. It treats its various multicultural patients with kindness and compassion. CHA Health Systems, a dynamic global healthcare corporation with 86 hospitals and clinics, 30 research and 14 education institutes, along with 31 bio/pharmaceutical/healthcare enterprises, provides a wide range of services in seven countries.

Read More

DIGITAL HEALTHCARE

Commure Introduces New Model to Accelerate Transformation in Healthcare with CommureOS

Commure | November 14, 2022

To help healthcare organizations hurdle long-standing barriers to meaningful transformation and drive exponential innovation at scale, Commure, Inc. today introduced CommureOS, a revolutionary transformation platform purpose-built for healthcare, at HLTH 2022. CommureOS is designed to give healthcare organizations the power to synthesize and maximize their existing solutions as well as easily build and rapidly deploy intelligent workflows to enhance clinical, operational, and financial efficiency. By reconciling information through a single platform and facilitating easy and connected innovation, CommureOS enables hospitals and health systems to streamline their technology experience, empower their healthcare workforce, and enhance care delivery and outcomes. “For decades, health organizations have been pushed to innovate at near-impossible speeds to keep up with the industry’s rate of change — and have made remarkable strides despite it all, More than ever, they deserve a robust tech experience that ensures their progress can endure. Over the past five years, we’ve been quietly and responsibly building a new model of innovation with some of our nation’s biggest health systems — and today, we invite pioneering organizations to embark with us on a new era of healthcare transformation.” -Ashwini Zenooz, MD, CEO of Commure With CommureOS, healthcare organizations can more effectively and efficiently: Unlock and connect disparate data points and static insights across their technology ecosystem and make them actionable and helpful at the point of care. Create, test, and deploy new solutions to solve their unique challenges with modular and industry-native building blocks — turning months of development into hours of configuration. Reuse established clinical and non-clinical data connections and extend across multiple use cases and workflows to seamlessly scale innovation throughout their organization. At a time when hospitals and health systems across the country are grappling with rising burnout and attrition, Commure is steadfast in our commitment to empower the healthcare workforce by simplifying and optimizing the tasks they do and the workflows they use every day, By helping health organizations derive meaning from mountains of data and build connected solutions at scale, we can finally ensure that people — rather than technology — are at the heart of our healthcare ecosystem,said Abhijit Mitra, chief product and engineering officer at Commure. With CommureOS, leading health systems and hospitals have the tools and support to create or customize the organizational workflows they need with ease, enabling them to streamline traditionally manual and time-consuming tasks and cultivate a more dynamic experience for clinicians, staff, and care delivery teams. There’s a new generation of digital health innovators keeping health systems at the center of their own transformation journeys — and Commure is at the forefront, Migrating from point solutions to platform is essential for technology-driven transformation of the sector. By connecting the dots and driving exceptional experiences, Commure is advancing our collective pursuit of responsible and enduring innovation,said Hemant Taneja, CEO and managing director at General Catalyst and co-founder of Commure. About Commure Commure, Inc. is building the first operating system designed for healthcare. By connecting disparate datasets, surfacing meaningful insights, accelerating performance through a suite of intuitive applications, and enabling seamless innovation across the industry, we empower every person in the health ecosystem to deliver exceptional care. Commure’s original applications include solutions to improve staff safety, enhance clinical workflow, and bolster financial operations. Commure is partnering with health systems, payors, and digital innovators to build a vibrant health ecosystem together; currently, the company enables more than 160,000 clinicians and staff across more than 400 care facilities to advance care through collaboration.

Read More